NGM Biopharmaceuticals (NGM) Competitor Comparison
We are evaluating the key criteria listed to compare NGM Biopharmaceuticals (NGM) against its competitors in the Biotechnology industry.
Market Capitalization
245 / 368Gross Profits
246 / 278Total Revenue
158 / 300EBITDA
250 / 337Free Cashflow
268 / 352Quick Ratio
122 / 357Earnings per Share
191 / 359Dividend yield
0 / 6Total Cash
177 / 358Performance 3 years
325 / 368Performance 5 years
266 / 368Performance 10 years
231 / 368Linearity 3 years
239 / 368Linearity 5 years
142 / 368Linearity 10 years
122 / 367Total Rank
208 / 368Dividend Rank
217 / 368Valuation Rank
306 / 368Piotroski Rank
333 / 368Muliplier Rank
96 / 368Market Capitalization - NGM ranking 245 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.